Showing 3,821 - 3,840 results of 18,267 for search 'significant ((((a decrease) OR (teer decrease))) OR (mean decrease))', query time: 0.56s Refine Results
  1. 3821
  2. 3822

    BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

    Published 2024
    “…(C) Compared to control, BT9 treatment significantly decreased the number of invading DAOY and D425 cells (****p < 0.0001, BT9 vs vehicle control, n = 6). 4x magnification.…”
  3. 3823
  4. 3824
  5. 3825
  6. 3826

    S1 Data - by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  7. 3827

    Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>. by Hao Deng (409186)

    Published 2024
    “…AA (OR = 3.016) and CA (OR = 2.130) genotypes were identified as risk factors for stage II. ERCC1 significantly decreased in processing of CWP. The cutoff value of ERCC1 was 5.265 pg/ml, with a sensitivity of 90.0% and specificity of 86.7%. …”
  8. 3828
  9. 3829

    Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

    Published 2025
    “…Beginning from day 28, when the solid tumors are of ~100mm<sup>3</sup> size, control and experimental mice were administered with drugs every other day for 18 days (total duration 46 days); on day 46, the mice were sacrificed and blood, vital organs and tumors were harvested for further analysis (b) Administration of STZ increased fasting blood sugar in mice: In order to establish hyperglycaemic state, mice were administered with low-dose STZ as detailed in methods section and blood sugar content determined using Morepen glucose monitoring strips. The data showed a significant increase in fasting blood glucose (FBG) beginning from day 6. …”
  10. 3830
  11. 3831
  12. 3832
  13. 3833

    Image 1_The effect of Traumeel LT ad us. vet. on the perioperative inflammatory response after castration of stallions: a prospective, randomized, double-blinded study.tif by Julia Laves (19779357)

    Published 2024
    “…</p>Results<p>The main variable SAA was increased after surgery reaching a mean value of 122 µg/ml in the FL group and a mean SAA of 226 µg/ml in the TR group 48 h after surgery, reaching a significant difference only at the 24 h timepoint (p = 0.03). …”
  14. 3834

    Table 2_The effect of Traumeel LT ad us. vet. on the perioperative inflammatory response after castration of stallions: a prospective, randomized, double-blinded study.docx by Julia Laves (19779357)

    Published 2024
    “…</p>Results<p>The main variable SAA was increased after surgery reaching a mean value of 122 µg/ml in the FL group and a mean SAA of 226 µg/ml in the TR group 48 h after surgery, reaching a significant difference only at the 24 h timepoint (p = 0.03). …”
  15. 3835

    Table 1_The effect of Traumeel LT ad us. vet. on the perioperative inflammatory response after castration of stallions: a prospective, randomized, double-blinded study.docx by Julia Laves (19779357)

    Published 2024
    “…</p>Results<p>The main variable SAA was increased after surgery reaching a mean value of 122 µg/ml in the FL group and a mean SAA of 226 µg/ml in the TR group 48 h after surgery, reaching a significant difference only at the 24 h timepoint (p = 0.03). …”
  16. 3836
  17. 3837
  18. 3838
  19. 3839
  20. 3840

    Table 1_LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity.docx by Miriam Moscoso (345679)

    Published 2025
    “…We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 ΔmurI, which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. …”